Abstract:TCF12, which is known to be involved in the regulation of cell growth and differentiation, has been reported to function as an oncogene or a tumor suppressor gene in the progression of various malignant tumors. However, its function and molecular mechanism in hepatocellular carcinoma (HCC) remain unclear. Methods: Stable ectopic TCF12 expression or knockdown in HCC cell lines was established by lentiviral infection. Then, MTT, colony formation, migration, invasion and HUVECs tube formation assays as well as an orthotopic xenograft model were used to investigate the biologic function of TCF12 in HCC cells in vitro and in vivo. Subsequently, RNA-Seq analysis was utilized to explore the target genes regulated by TCF12. RT-qPCR, western blotting, a dual-luciferase reporter assay, Ch-IP, CHIP-Seq and functional rescue experiments were used to confirm the target gene regulated by TCF12. Finally, RT-qPCR, western blot and immunohistochemical (IHC) staining were performed to detect the expression level of TCF12 and to analyze the correlation of TCF12 with downstream genes as well as the clinical significance of TCF12 in human primary HCC. Results: Our functional studies revealed that stable overexpression of TCF12 in human HCC cells enhanced cell proliferation, migration and invasion in vitro and in vivo, whereas knockdown of TCF12 showed opposing effects. Mechanistically, CXCR4 was a downstream target of TCF12, and TCF12 directly bound to the CXCR4 promoter to regulate its expression. Moreover, CXCR4, with its ligand CXCL12, played a critical role in tumor progression induced by TCF12 via activation of the MAPK/ERK and PI3K/AKT signaling pathways. Clinically, IHC analysis revealed that TCF12 was significantly associated with poor survival of HCC patients and that TCF12 expression was closely correlated with CXCR4 expression in primary HCC tissues. Conclusion: Our findings are the first to indicate that TCF12 could promote the tumorigenesis and progression of HCC mainly by upregulating CXCR4 expression and is a prognostic indicator for patients with HCC.

Overexpression of Galectin-4 Promotes Cell Growth of Hepatocellular Carcinoma Cells in Vitro and in Vivo.

Expression Of Galectin-9 Mrna In Hepatocellular Carcinoma

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

Overexpression of Galectin‐1 is Associated with Poor Prognosis in Human Hepatocellular Carcinoma Following Resection

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK|[sol]|PI3K|[sol]|AKT signaling

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

Expression of Galectin-1 in Carcinoma-Associated Fibroblasts Promotes Gastric Cancer Cell Invasion Through Upregulation of Integrin Beta 1

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.

Hypoxia-inducible Factor 1 Alpha-Activated Angiopoietin-Like Protein 4 Contributes to Tumor Metastasis Via Vascular Cell Adhesion Molecule-1/Integrin Β1 Signaling in Human Hepatocellular Carcinoma.

Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma.

Downregulation of Galectin-3 Causes A Decrease in Upar Levels and Inhibits the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells

Hepatocyte nuclear factor 4 gamma (HNF4G) is correlated with poor prognosis and promotes tumor cell growth by inhibiting caspase-dependent intrinsic apoptosis in colorectal cancer

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

Association Between G-protein Coupled Receptor 4 Expression and Microvessel Density, Clinicopathological Characteristics and Survival in Hepatocellular Carcinoma

Autophagy Drives Galectin-1 Secretion From Tumor-Associated Macrophages Facilitating Hepatocellular Carcinoma Progression

Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma

Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts

Effect of Deletion of ANGPTL4 Gene on Viability, Migration and Invasion Ability and Apoptosis of Hepatocellular Carcinoma Cells

Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.

A Tumor Suppressor Enhancing Module Orchestrated by GATA4 Denotes a Therapeutic Opportunity for GATA4 Deficient HCC Patients